Clinical trial
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
NCT00003138 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
- Lead sponsor
- Eastern Cooperative Oncology Group
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 4, 1998
- Completion date
- May 31, 2014
- Enrollment
- 118 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.